Table 3 DAS28 scores and disease activity levels by treatment group in 2018 and 2023
Group | DAS28 2018 | Remission 2018 (%) | Low 2018 (%) | Moderate 2018 (%) | High 2018 (%) | DAS28 2023 | Remission 2023 (%) | Low 2023 (%) | Moderate 2023 (%) | High 2023 (%) |
|---|---|---|---|---|---|---|---|---|---|---|
MTX (n = 42) | 1.72 | 90% | 10% | 0% | 0% | 2.46 | 50% | 25% | 18.75% | 6.25% |
Bio (n = 115) | 1.71 | 92.86% | 0% | 7.4% | 0% | 2.77 | 45.45% | 9.09% | 45.45% | 0% |
MTX + Bio (n = 33) | 2.1 | 73.53% | 5.88% | 17.65% | 2.94% | 2.1 | 75% | 12.5% | 12.5% | 0% |
Miscellaneous (n = 16) | 2.4 | 53.33% | 20% | 22.22% | 4.44% | 3.1 | 25% | 20.45% | 43.18% | 11.36% |